Characterization of serological responses to pertussis

Clinical and Vaccine Immunology : CVI
Mineo WatanabeAlison A Weiss

Abstract

We have compared the use of five nonvaccine antigens to the use of conventional vaccine antigens, pertussis toxin (PT), and filamentous hemagglutinin (FHA) for the serological diagnosis of pertussis by enzyme-linked immunosorbent assay (ELISA). The nonvaccine antigens included the catalytic region of adenylate cyclase toxin (CatACT), the C-terminal region of FHA (C-FHA), lipooligosaccharide (LOS), the peptidoglycan-associated lipoprotein (PAL), and the BrkA protein. The serological responses of individuals with culture-confirmed pertussis were compared to those of adults with no recent history of a coughing disease. An immunoglobulin G (IgG) ELISA for PT was the most sensitive (92.2%) test for the serodiagnosis of pertussis. Of the nonvaccine antigens, ELISA for IgG responses to CatACT (sensitivity, 62.8%), C-FHA (sensitivity, 39.2%), and LOS IgA (sensitivity, 29.4%) were less sensitive but could also distinguish culture-positive individuals from control individuals. The use of a combination of multiple ELISA targets improved the sensitivity of the assay for serological diagnosis. Elevated IgG and IgA antibody titers persisted for more than a year in the individuals with culture-confirmed pertussis.

References

Jan 14, 1991·FEBS Letters·I E EhrmannE L Hewlett
Feb 1, 1991·FEMS Microbiology Letters·F D MenozziC Locht
Jul 1, 1989·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·P Chong, M Klein
Nov 1, 1994·Infection and Immunity·R C Fernandez, A A Weiss
Apr 1, 1993·FEMS Immunology and Medical Microbiology·J L ArciniegaD L Burns
Jan 1, 1996·Infection and Immunity·M E Bauer, R A Welch
Feb 26, 2000·Infection and Immunity·C L Weingart, A A Weiss
Apr 11, 2001·The Journal of Infectious Diseases·P StrebelW Wattigney
May 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L D SenziletUNKNOWN Sentinel Health Unit Surveillance System Pertussis Working Group
Aug 25, 2001·Journal of Endotoxin Research·M CaroffD Karibian
Sep 25, 2001·Vaccine·D C Oliver, R C Fernandez
Jun 29, 2002·BMJ : British Medical Journal·N S Crowcroft, Joseph Britto
Mar 12, 2003·The Journal of Experimental Medicine·Loic CoutteFrancoise Jacob-Dubuisson
May 2, 2003·The Journal of Infectious Diseases·Paula S Mobberley-SchumanAlison A Weiss
Feb 7, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James D CherryMichael J Corbel
Oct 16, 2004·Expert Review of Anti-infective Therapy·Mineo Watanabe, Masaaki Nagai
Dec 4, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin D ForsythUNKNOWN Global Pertussis Initiative
Feb 16, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Alberto E TozziStefania Salmaso
Mar 25, 2005·The New England Journal of Medicine·Erik L Hewlett, Kathryn M Edwards

❮ Previous
Next ❯

Citations

Apr 20, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N KennerknechtC H Wirsing von König
Jan 24, 2009·The Pediatric Infectious Disease Journal·John B RobbinsBirger Trollfors
Sep 8, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Tine Dalby, Karen A Krogfelt
Apr 28, 2012·Clinical and Vaccine Immunology : CVI·Lucia C PawloskiMaria Lucia Tondella
Jan 19, 2012·Infection and Immunity·Jason M WarfelTod J Merkel
Oct 9, 2009·Journal of Perinatology : Official Journal of the California Perinatal Association·J H ShakibC L Byington
Nov 23, 2011·Critical Reviews in Microbiology·Asma ZouariAmel Kechrid
Aug 22, 2014·Expert Review of Vaccines·Carl-Heinz Wirsing von König
Aug 5, 2014·Expert Review of Vaccines·Peter SeboJiri Masin
Jul 3, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kaoru OguchiTetsuo Nakayama
Aug 8, 2008·Respiratory Medicine·Anastasios M KapaskelisMatthew E Falagas
Jul 28, 2016·Journal of the Pediatric Infectious Diseases Society·Lucia C PawloskiM Lucia Tondella
Apr 20, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Pedro Plans
Jun 20, 2018·The Journal of Clinical Investigation·Ricardo da Silva AntunesAlessandro Sette
Sep 26, 2014·Clinical and Vaccine Immunology : CVI·Olajumoke O FadugbaNatasha B Halasa
Sep 12, 2015·Clinical Microbiology Reviews·Anneke van der ZeeFrits R Mooi
Oct 30, 2009·Clinical and Vaccine Immunology : CVI·Sandra L MenziesUNKNOWN Pertussis Assay Working Group
Dec 17, 2014·The Journal of Biological Chemistry·Xianzhe WangJennifer A Maynard
Oct 15, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L SubissiI Desombere
Jul 22, 2021·Emerging Infectious Diseases·Illiassou Hamidou SoumanaEric T Harvill

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.